BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma-Reference-Cited by-同舟云学术

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma

Published:2020-05-27 Issue:6 Volume:40 Page:245-259
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Tian Xiao‐Peng¹²,Cai Jun²,Ma Shu‐Yun²,Fang Yu²,Huang Hui‐Qiang²,Lin Tong‐Yu²,Rao Hui‐Lan³,Li Mei³,Xia Zhong‐Jun⁴,Kang Tie‐Bang¹,Xie Dan¹,Cai Qing‐Qing¹²^ORCID

Affiliation:

1. State Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer MedicineSun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China

2. Department of Medical OncologySun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China

3. Department of PathologySun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China

4. Department of HematologySun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China

Funder

Special Support Program of Sun Yat-sen University Cancer Center

National Key R&D Program of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12039

Reference39 articles.

1. Lymphoblastic lymphoma

2. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

3. Adult Lymphoblastic Lymphoma

4. Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population‐based cluster analysis;Gu X;Cancer Commun,2018

5. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives;Signal Transduction and Targeted Therapy;2024-08-02

2. Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases;Journal of Pharmacology and Experimental Therapeutics;2024-04-02

3. Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives;Cell Cycle;2024-03-18

4. RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP;BMC Cancer;2024-01-12

5. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances;MedComm – Oncology;2024-01-04